Vir Biotechnology, Inc. (VIR) SEC Filings & Financial Intelligence
Vir Biotechnology, Inc. (VIR) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VIR
CIK: 1706431
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerRichard Shunn
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-11-06 | — | SCHEDULE 13D/A Filing | 0001012975-26-001020 | View SEC Doc Filr Page |
| 10-Q | 2026-11-04 | 2026-09-30 | 10-Q | 0001628280-26-070273 | View SEC Doc Filr Page |
| 8-K | 2026-11-04 | 2026-11-04 | 8-K | 0001628280-26-070148 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-02 | FORM 4 | 0001628280-26-070025 | View SEC Doc Filr Page |
| 144 | 2026-11-03 | — | 144 Filing | 0001959173-26-007669 | View SEC Doc Filr Page |
| 144 | 2026-11-02 | — | 144 Filing | 0001959173-26-007634 | View SEC Doc Filr Page |
| 4 | 2026-10-28 | 2026-10-27 | FORM 4 | 0001628280-26-067824 | View SEC Doc Filr Page |
| 3 | 2026-10-28 | 2026-10-27 | FORM 3 | 0001628280-26-067822 | View SEC Doc Filr Page |
| 8-K | 2026-10-28 | 2026-10-26 | 8-K | 0001628280-26-067742 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-003861 | View SEC Doc Filr Page |
| 8-K | 2026-10-14 | 2026-10-09 | 8-K | 0001628280-26-065826 | View SEC Doc Filr Page |
| 8-K | 2026-10-08 | 2026-10-08 | 8-K | 0001628280-26-065408 | View SEC Doc Filr Page |
| 3 | 2026-10-06 | 2026-10-05 | FORM 3 | 0001628280-26-065222 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-10-01 | 8-K | 0001628280-26-064117 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001959173-26-007020 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001959173-26-006814 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001959173-26-006425 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001959173-26-006413 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001959173-26-006329 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-11 | FORM 4 | 0001628280-26-056108 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000556 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001628280-26-053549 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001628280-26-053351 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-31 | — | SCHEDULE 13G/A Filing | 0002100121-26-000992 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-20 | 8-K | 0001628280-26-049499 | View SEC Doc Filr Page |